HEALTH PRISM Trademark

Trademark Overview

On Friday, September 9, 2005, a trademark application was filed for HEALTH PRISM with the United States Patent and Trademark Office. The USPTO has given the HEALTH PRISM trademark a serial number of 79031597. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Wednesday, September 9, 2015. This trademark is owned by Geneos Oy. The HEALTH PRISM trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical research, pharmaceutical development services in the fields of molecular medicine, clinical studies and health care, namely, scientific research consulting for improved clinical trial design; pharmaceutical research in the field of molecular medicine featuring modeling of clinical trials; medical research that analyzes data to identify patterns across patient groups or disease progression; medical research, namely, identification and validation of disease characteristics in specific gene biomarkers, protein biomarkers and metabolite biomarkers for use in drug development, molecular diagnostics and improved patient care; medical research featuring the discovery and validation of biomarkers for the association with disease phenotype, namely, validating the clinical relevance of biomarkers and characterizing new biomarkers
health prism

General Information

Serial Number79031597
Word MarkHEALTH PRISM
Filing DateFriday, September 9, 2005
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateWednesday, September 9, 2015
Registration Number3468020
Registration DateTuesday, July 15, 2008
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 29, 2008

Trademark Statements

Disclaimer with Predetermined Text"HEALTH"
Goods and ServicesMedical research, pharmaceutical development services in the fields of molecular medicine, clinical studies and health care, namely, scientific research consulting for improved clinical trial design; pharmaceutical research in the field of molecular medicine featuring modeling of clinical trials; medical research that analyzes data to identify patterns across patient groups or disease progression; medical research, namely, identification and validation of disease characteristics in specific gene biomarkers, protein biomarkers and metabolite biomarkers for use in drug development, molecular diagnostics and improved patient care; medical research featuring the discovery and validation of biomarkers for the association with disease phenotype, namely, validating the clinical relevance of biomarkers and characterizing new biomarkers

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, February 20, 2015
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGeneos Oy
Party Type30 - Original Registrant
Legal Entity Type09 - Joint Stock Company
AddressFI
Party NameGeneos Oy
Party Type20 - Owner at Publication
Legal Entity Type09 - Joint Stock Company
AddressFI
Party NameGeneos Oy
Party Type10 - Original Applicant
Legal Entity Type09 - Joint Stock Company
AddressFI

Trademark Events

Event DateEvent Description
Friday, April 1, 2016NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Friday, April 1, 2016DEATH OF INTERNATIONAL REGISTRATION
Wednesday, December 30, 2015TOTAL INVALIDATION PROCESSED BY THE IB
Monday, December 7, 2015TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Monday, December 7, 2015INVALIDATION PROCESSED
Tuesday, October 20, 2015TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, February 20, 2015CANCELLED SECTION 71
Saturday, December 29, 2012FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, October 31, 2008FINAL DISPOSITION NOTICE SENT TO IB
Friday, October 31, 2008FINAL DISPOSITION PROCESSED
Wednesday, October 15, 2008FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, July 15, 2008REGISTERED-PRINCIPAL REGISTER
Thursday, May 29, 2008NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Thursday, May 15, 2008NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Thursday, May 15, 2008NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Tuesday, April 29, 2008PUBLISHED FOR OPPOSITION
Wednesday, April 9, 2008NOTICE OF PUBLICATION
Monday, March 24, 2008LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, March 24, 2008ASSIGNED TO LIE
Wednesday, March 19, 2008APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 11, 2008EXAMINER'S AMENDMENT ENTERED
Friday, March 7, 2008NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, March 7, 2008EXAMINERS AMENDMENT E-MAILED
Friday, March 7, 2008EXAMINERS AMENDMENT -WRITTEN
Friday, August 10, 2007NOTIFICATION OF FINAL REFUSAL EMAILED
Friday, August 10, 2007FINAL REFUSAL E-MAILED
Friday, August 10, 2007FINAL REFUSAL WRITTEN
Wednesday, July 18, 2007AMENDMENT FROM APPLICANT ENTERED
Wednesday, July 18, 2007CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, July 18, 2007ASSIGNED TO LIE
Thursday, June 28, 2007PAPER RECEIVED
Tuesday, May 29, 2007ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, May 29, 2007TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, January 18, 2007REFUSAL PROCESSED BY IB
Friday, December 29, 2006NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, December 29, 2006REFUSAL PROCESSED BY MPU
Wednesday, December 20, 2006NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, December 19, 2006NON-FINAL ACTION WRITTEN
Friday, December 15, 2006ASSIGNED TO EXAMINER
Friday, December 15, 2006NEW APPLICATION ENTERED IN TRAM
Thursday, December 14, 2006SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

prism health biomarkers research clinical medical namely molecular disease featuring care improved